Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes - PubMed (original) (raw)
Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes
A Bendelac. J Exp Med. 1995.
Abstract
Mouse NK1+ T cells constitute a subset of alpha/beta TCR+ T cells that specialize in the rapid production of cytokines, in particular IL-4, and may promote the differentiation of Th2-type CD4 T cells. Their TCRs, like those of a homologous subset of human T cells, use an invariant TCR alpha chain and were recently shown to be specific for the beta 2-microglobulin-associated, MHC class I-like CD1 molecules, which are encoded outside the MHC. In contrast to mainstream thymocytes, which recognize their positively selecting MHC ligand on thymic epithelial cells, positive selection of NK1+ T cells requires their CD1 ligand to be expressed on bone marrow-derived cells. To investigate the nature of the bone marrow-derived cell involved, chimeric mice were constructed with tissues from normal, SCID, and MHC-deficient mice, so that CD1 could be selectively expressed by different subsets of bone marrow-derived cells in the thymus. CD1 expression was also directly assessed using an anti-CD1 mAb, and a CD1-specific T cell hybridoma. The results suggest that immature (CD4+8+ double-positive) cortical thymocytes are the source of CD1 presentation for positive selection of NK1+ T cells.
Similar articles
- A NK1.1+ thymocyte-derived TCR beta-chain transgene promotes positive selection of thymic NK1.1+ alpha beta T cells.
Viret C, Lantz O, He X, Bendelac A, Janeway CA Jr. Viret C, et al. J Immunol. 2000 Sep 15;165(6):3004-14. doi: 10.4049/jimmunol.165.6.3004. J Immunol. 2000. PMID: 10975809 - IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
Hameg A, Gouarin C, Gombert JM, Hong S, Van Kaer L, Bach JF, Herbelin A. Hameg A, et al. J Immunol. 1999 Jun 15;162(12):7067-74. J Immunol. 1999. PMID: 10358149 - Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
Schulz RJ, Parkes A, Mizoguchi E, Bhan AK, Koyasu S. Schulz RJ, et al. J Immunol. 1996 Nov 15;157(10):4379-89. J Immunol. 1996. PMID: 8906813 - Mouse NK1+ T cells.
Bendelac A. Bendelac A. Curr Opin Immunol. 1995 Jun;7(3):367-74. doi: 10.1016/0952-7915(95)80112-x. Curr Opin Immunol. 1995. PMID: 7546402 Review. - Mouse CD1-specific NK1 T cells: development, specificity, and function.
Bendelac A, Rivera MN, Park SH, Roark JH. Bendelac A, et al. Annu Rev Immunol. 1997;15:535-62. doi: 10.1146/annurev.immunol.15.1.535. Annu Rev Immunol. 1997. PMID: 9143699 Review.
Cited by
- Thymic development of human natural killer T cells: recent advances and implications for immunotherapy.
Pellicci DG, Tavakolinia N, Perriman L, Berzins SP, Menne C. Pellicci DG, et al. Front Immunol. 2024 Aug 29;15:1441634. doi: 10.3389/fimmu.2024.1441634. eCollection 2024. Front Immunol. 2024. PMID: 39267746 Free PMC article. Review. - Unraveling the phenotypic states of human innate-like T cells: Comparative insights with conventional T cells and mouse models.
Loh L, Carcy S, Krovi HS, Domenico J, Spengler A, Lin Y, Torres J, Prabakar RK, Palmer W, Norman PJ, Stone M, Brunetti T, Meyer HV, Gapin L. Loh L, et al. Cell Rep. 2024 Sep 24;43(9):114705. doi: 10.1016/j.celrep.2024.114705. Epub 2024 Sep 10. Cell Rep. 2024. PMID: 39264810 Free PMC article. - SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y, Quan Y, He J, Chen S, Dong Z. Wang Y, et al. Nat Commun. 2024 Jun 13;15(1):5056. doi: 10.1038/s41467-024-49466-9. Nat Commun. 2024. PMID: 38871792 Free PMC article. - PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.
Moraes Ribeiro E, Secker KA, Nitulescu AM, Schairer R, Keppeler H, Wesle A, Schmid H, Schmitt A, Neuber B, Chmiest D, Podavini S, Märklin M, Klimovich B, Schmitt M, Korkmaz F, Lengerke C, Schneidawind C, Schneidawind D. Moraes Ribeiro E, et al. J Immunother Cancer. 2024 Jan 31;12(1):e007829. doi: 10.1136/jitc-2023-007829. J Immunother Cancer. 2024. PMID: 38296597 Free PMC article. - The promiscuous development of an unconventional Qa1b-restricted T cell population.
Manoharan Valerio M, Arana K, Guan J, Chan SW, Yang X, Kurd N, Lee A, Shastri N, Coscoy L, Robey EA. Manoharan Valerio M, et al. Front Immunol. 2023 Oct 31;14:1250316. doi: 10.3389/fimmu.2023.1250316. eCollection 2023. Front Immunol. 2023. PMID: 38022509 Free PMC article.
References
- J Exp Med. 1994 Sep 1;180(3):1171-6 - PubMed
- J Exp Med. 1994 Sep 1;180(3):1097-106 - PubMed
- J Immunol. 1984 Sep;133(3):1111-6 - PubMed
- Cell. 1985 Dec;43(2 Pt 1):543-50 - PubMed
- J Exp Med. 1987 Aug 1;166(2):577-82 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials